Provided by North American Center for Continuing Medical Education, LLC (NACCME), an HMP Company.
This activity is designed for general and specialty neurologists, psychiatrists, neurology and psychiatric NPs, advanced practice nurses (APRNs), PAs, nurses, and other healthcare practitioners who care for patients with early AD.
For questions regarding this educational activity, please call 609-371-1137 or email firstname.lastname@example.org.
After participating in this activity, learners should be better able to:
To be eligible for credit, participants must complete the online activity and the evaluation. Upon completing the activity, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit.
NACCME would like to thank the following company who has supported "Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease" through educational grants and/or in-kind support: Biogen
In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Estimated Time to Complete: 0.25 hour
NACCME designates this internet enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This continuing nursing education activity awards 0.25 contact hour.
NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 credits. PAs should only claim credit commensurate with the extent of their participation.
USE OF PROPRIETARY NAMES
This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.